34573-39-2

Basic information

• Product Name: L-Phenylalanine, N-[(1,1-dimethylethoxy)carbonyl]-, chloromethyl ester
• CAS NO: 34573-39-2
• Molecular Formula: C15H20ClNO4
• Molecular Weight: 313.781
• Mol File: 34573-39-2.mol
• Article Data: 6

Chemical Properties

• CAS DataBase Reference: L-Phenylalanine, N-[(1,1-dimethylethoxy)carbonyl]-, chloromethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: L-Phenylalanine, N-[(1,1-dimethylethoxy)carbonyl]-, chloromethyl ester(34573-39-2)
• EPA Substance Registry System: L-Phenylalanine, N-[(1,1-dimethylethoxy)carbonyl]-, chloromethyl ester(34573-39-2)

Safety Data

• Hazardous Substances Data: 34573-39-2(Hazardous Substances Data)

Upstream product

• 593-71-5 Chloroiodomethane 
• 13734-34-4 N-tert-butoxycarbonyl-L-phenylalanine 
• 74-97-5 chlorobromomethane 
• 42538-61-4 N-t-butyloxycarbonyl-phenylalanine cesium salt 

Downstream Products

• 942123-48-0 iodomethyl N-(t-butoxycarbonyl)-L-phenylalaninate 
• 928651-99-4 2-tert-butoxycarbonylamino-3-phenyl-propionic acid [2-(6-amino-purin-9-yl)-ethoxymethyl]-(2-tert-butoxycarbonylamino-3-phenyl-propionyloxymethoxy)-phosphinoyloxymethyl ester 
• 70579-79-2 (6R)-7t-((R)-2-hydroxy-2-phenyl-acetylamino)-3-(1-methyl-1H-tetrazol-5-ylsulfanylmethyl)-8-oxo-(6rH)-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid (N-tert-butoxycarbonyl-L-phenylalanyloxy)-methyl ester 
• 1051916-44-9 (S)-2-tert-butoxycarbonylamino-3-phenylpropionic acid 5-(4-dimethylaminonaphthalen-1-ylazo)benzotriazol-2-ylmethyl ester 
• 179744-30-0 (S)-2-tert-Butoxycarbonylamino-3-phenyl-propionic acid 3-[(2R,4S,5R)-4-(4-chloro-benzyloxy)-5-hydroxymethyl-tetrahydro-furan-2-yl]-5-fluoro-2,6-dioxo-3,6-dihydro-2H-pyrimidin-1-ylmethyl ester 

Relevant articles and documents

POMALIDOMIDE DERIVATIVE AND PREPARATION METHOD THEREFOR

Disclosed in the present invention are a Pomalidomide derivative and a preparation method therefor. Specifically, the present invention relates to the Pomalidomide derivative and a stereoisomer thereof, or a pharmaceutically acceptable salt, and applications thereof in the preparation of drugs for treating cancers.

Compositions and methods for treating viral infections

The present invention provides compositions methods for treating susceptible viral infections, especially hepatitis C viral (HCV) infections as well as co infections of HCV with other viruses such as HBV and/or HIV. In one embodiment, the present inventio

Nucleotide and oligonucleotide prodrugs

The present invention discloses compounds of formula (I): which exhibit antiviral properties. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject in need of anti-HBV